Alp Invest Partners B.V. Syros Pharmaceuticals, Inc. Transaction History

Alp Invest Partners B.V.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2020 Aug 13, 2020	SELL	$5.21 - $11.03 $78,150 - $165,450	-15,000 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$4.46 - $9.2 $66,900 - $138,000	15,000 New	15,000 $89,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Alp Invest Partners B.V., based on Form 13F filings with the SEC.

Stay updated on Alp Invest Partners B.V. with notifications on news.